SCHEMBL8123473

SCHEMBL8123473

COc1ccc(-c2cc3ccc(OC(C)=O)c(OC(C)=O)c3oc2=O)cc1

nearest known ligand 0.86

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ADORA3 P0DMS8 7/20 0.86
▸ ADORA2A P29274 4/20 0.76
▸ ADORA1 P30542 2/20 0.76
▸ TMIGD3 P0DMS9 2/20 0.67
▸ NPC1 O15118 4/20 0.59
▸ RAB9A P51151 4/20 0.59
▸ MEN1 O00255 3/20 0.59
▸ KMT2A Q03164 3/20 0.59
▸ BACE1 P56817 1/20 0.56
▸ MAOB P27338 3/20 0.54
▸ RXFP1 Q9HBX9 3/20 0.53
▸ GAPDH P04406 2/20 0.53
▸ MIF P14174 1/20 0.53
▸ SIRT3 Q9NTG7 1/20 0.53
▸ ERAP1 Q9NZ08 1/20 0.53
▸ KDM4E B2RXH2 1/20 0.51
▸ GLA P06280 1/20 0.51
▸ MAPT P10636 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8107293 0.93 ADORA3 (1.00) ADORA3ADORA2AADORA1TMIGD3NPC1
SCHEMBL28585336 0.91 ADORA3 (0.74) ADORA3ADORA2AADORA1TMIGD3NPC1
SCHEMBL8116456 0.88 ADORA3 (0.82) ADORA3ADORA2AADORA1TMIGD3NPC1
SCHEMBL8115217 0.87 ADORA3 (0.80) ADORA3ADORA2AADORA1TMIGD3NPC1
SCHEMBL8115882 0.87 ADORA3 (0.80) ADORA3ADORA2AADORA1TMIGD3NPC1
SCHEMBL8122887 0.87 ADORA3 (0.80) ADORA3ADORA2AADORA1TMIGD3NPC1
SCHEMBL8116819 0.86 ADORA3 (0.80) ADORA3ADORA2AADORA1TMIGD3NPC1
SCHEMBL28585964 0.83 ADORA3 (0.72) ADORA3ADORA2AADORA1TMIGD3NPC1
SCHEMBL8116146 0.83 ADORA3 (0.73) ADORA3ADORA2AADORA1TMIGD3NPC1
SCHEMBL8117382 0.80 ADORA2A (0.78) ADORA3ADORA2AADORA1TMIGD3NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020130120-A1 CANCER METASTASIS INHIBITOR 学校法人京都薬科大学 2020-06-25 — — WO disclosed
WO-2020130120-A1 CANCER METASTASIS INHIBITOR 学校法人京都薬科大学 2020-06-25 — — WO disclosed
EP-0645382-B1 COUMARIN DERIVATIVE AND USE THEREOF MORINAGA MILK INDUSTRY CO LTD (JP) 2000-07-12 — — EP disclosed
US-5574062-A COMPOUNDS HAVE 3-ARYL AND 7-HYDROXY OR -ACYLOXY; USE TO INHIBIT 12-LIPOXYGENASE MORINAGA MILK INDUSTRY CO., LTD. (JP) 1996-11-12 — — US disclosed
EP-0645382-A1 COUMARIN DERIVATIVE AND USE THEREOF MORINAGA MILK INDUSTRY CO., LTD. (JP) 1995-03-29 — — EP disclosed
Send feedback